Unichem Labs - Unichem Laboratories Share Price

447.60-15.00 (-3.25%)

Closed
As On: 12 Jun, 2026, 03:58 PM IST
As On: 12 Jun, 2026, 03:55 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	449.00
High	462.30
Low	438.35
Prev Close	462.60
Volume	20,33,442
VWAP(₹)	452.67

Share Price	Value
Today/Current/Last	447.60446.10
Previous Day	462.60461.70

Unichem Labs Share Recommendations

Recent Recos

Target₹790
OrganizationSharekhan by BNP Paribas
HOLD

Target₹275.5
OrganizationGeojit BNP Paribas Financial Services
BUY ON DECLINES

View all Stock Recommendations

News & Analysis

From red to black: 50 companies turn losses into profit in Q3. Do you own them?
News
Buy, Sell or Hold: Motilal Oswal maintains buy on Jindal Stainless; HDFC Securities retain buy on IPCA Lab
News
These 5 smallcap stocks witnessed a rise in prices with volumes in 3 days
News
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Announcements

View all Unichem Labs Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	532.97	599.93	533.42	596.43	546.71
Total Income Growth (%)	-11.16	12.47	-10.56	9.09	16.09
Total Expenses	232.12	602.51	535.90	533.17	478.11
Total Expenses Growth (%)	-61.47	12.43	0.51	11.52	10.37
EBIT	300.85	-2.58	-2.48	63.26	68.60
EBIT Growth (%)	-	-	-103.92	-7.78	81.58
Profit after Tax (PAT)	264.29	-11.89	-10.47	52.97	57.85
PAT Growth (%)	-	-	-119.77	-8.44	89.73
EBIT Margin (%)	56.45	-0.43	-0.46	10.61	12.55
Net Profit Margin (%)	49.59	-1.98	-1.96	8.88	10.58
Basic EPS (₹)	37.54	-1.69	-1.49	7.52	8.22

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	329.93	378.30	388.50	467.29	466.76
Total Income Growth (%)	-12.79	-2.63	-16.86	0.11	5.14
Total Expenses	68.01	412.45	388.44	409.73	402.07
Total Expenses Growth (%)	-83.51	6.18	-5.20	1.91	0.83
EBIT	261.92	-34.15	0.06	57.56	64.69
EBIT Growth (%)	-	-0.01	-99.90	-11.02	43.15
Profit after Tax (PAT)	216.11	-39.93	-1.85	51.22	46.89
PAT Growth (%)	-	-	-103.61	9.23	8.12
EBIT Margin (%)	79.39	-9.03	0.02	12.32	13.86
Net Profit Margin (%)	65.50	-10.56	-0.48	10.96	10.05
Basic EPS (₹)	30.69	-5.67	-0.26	7.28	6.66

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	2,146.29	1,736.49	1,381.54	1,317.34	1,285.32
Total Revenue Growth (%)	23.60	25.69	4.87	2.49	7.56
Total Expenses	1,991.70	1,740.55	1,519.33	1,294.31	1,233.50
Total Expenses Growth (%)	14.43	14.56	17.39	4.93	-0.85
Profit after Tax (PAT)	137.52	-70.47	-202.23	33.06	34.32
PAT Growth (%)	-	-	-711.67	-3.68	-
Operating Profit Margin (%)	8.31	1.09	-8.97	2.29	4.61
Net Profit Margin (%)	6.51	-4.13	-15.05	2.60	2.77
Basic EPS (₹)	19.53	-10.01	-28.72	4.70	4.88

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,776.53	1,472.55	1,114.28	984.99	1,171.34
Total Revenue Growth (%)	20.64	32.15	13.13	-15.91	16.71
Total Expenses	1,597.85	1,507.13	1,280.71	1,071.74	1,105.70
Total Expenses Growth (%)	6.02	17.68	19.50	-3.07	3.59
Profit after Tax (PAT)	162.96	-92.18	-299.70	-55.43	54.08
PAT Growth (%)	-	-	-	-202.49	-
Operating Profit Margin (%)	10.73	-1.67	-14.64	-8.97	5.95
Net Profit Margin (%)	9.38	-6.39	-27.94	-5.87	4.81
Basic EPS (₹)	23.15	-13.09	-42.57	-7.87	7.68

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent 1.43% of its operating revenues towards interest expenses and 18.01% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	3,569.40	3,169.34	3,193.05	3,318.77	3,125.71
Total Assets Growth (%)	12.62	-0.74	-3.79	6.18	-0.60
Total Liabilities	1,118.81	806.93	757.74	700.36	568.88
Total Liabilities Growth (%)	38.65	6.49	8.19	23.11	-7.26
Total Equity	2,450.59	2,362.42	2,435.30	2,618.41	2,556.83
Total Equity Growth (%)	3.73	-2.99	-6.99	2.41	1.01
Current Ratio (x)	2.05	2.40	2.49	2.99	2.72
Total Debt to Equity (x)	0.18	0.09	0.12	0.13	0.04
Contingent Liabilities	154.73	78.64	221.70	145.39	561.98

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	3,109.21	2,863.70	2,886.14	3,122.08	3,119.06
Total Assets Growth (%)	8.57	-0.78	-7.56	0.10	3.10
Total Liabilities	649.46	569.07	501.87	450.04	421.72
Total Liabilities Growth (%)	14.13	13.39	11.52	6.72	11.58
Total Equity	2,459.75	2,294.63	2,384.27	2,672.04	2,697.33
Total Equity Growth (%)	7.20	-3.76	-10.77	-0.94	1.89
Current Ratio (x)	3.03	2.89	3.33	4.43	3.51
Total Debt to Equity (x)	0.05	0.03	0.04	0.05	0.00
Contingent Liabilities	266.92	105.21	300.51	294.41	311.26

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	-7.02	16.69	-85.09	-259.61	33.10
Net Cash used in Investing Activities	-241.23	50.40	202.81	100.12	-73.56
Net Cash flow from Financing Activities	183.76	-106.31	-81.30	191.23	-121.19
Net Cash Flow	-65.17	-32.84	74.56	31.74	-161.65
Closing Cash & Cash Equivalent	89.58	150.91	183.75	109.20	77.46
Closing Cash & Cash Equivalent Growth (%)	-40.64	-17.87	68.28	40.97	-66.54
Total Debt/ CFO (x)	-61.25	13.13	-3.50	-1.27	3.04

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	72.29	-41.57	-117.33	-158.31	-32.50
Net Cash used in Investing Activities	-132.07	53.24	202.50	104.03	-80.39
Net Cash flow from Financing Activities	-4.61	-48.06	-61.76	95.80	-45.19
Net Cash Flow	-65.07	-30.02	61.54	41.53	-158.07
Closing Cash & Cash Equivalent	60.58	125.65	155.67	94.13	52.60
Closing Cash & Cash Equivalent Growth (%)	-51.79	-19.28	65.38	78.95	-74.10
Total Debt/ CFO (x)	1.54	-1.54	-0.87	-0.80	0.00

All figures in Rs Cr, unless mentioned otherwise

View Details

Ratios

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	5.61	-2.98	-8.30	1.26	1.34
Return on Capital Employed (%)	6.81	0.75	-4.71	1.05	2.17
Return on Assets (%)	3.85	-2.22	-6.33	0.99	1.09
Interest Coverage Ratio (x)	14.27	5.82	-0.41	19.70	11.12
Asset Turnover Ratio (x)	0.63	0.54	0.41	0.30	39.51
Price to Earnings (x)	35.59	-49.02	-10.07	55.56	63.69
Price to Book (x)	1.99	1.46	0.84	0.70	0.85
EV/EBITDA (x)	17.29	26.58	-304.97	17.03	15.54
EBITDA Margin (%)	14.22	7.73	-0.52	9.47	11.43

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	6.62	-4.01	-12.56	-2.07	2.00
Return on Capital Employed (%)	7.19	-1.01	-6.28	-3.01	2.43
Return on Assets (%)	5.24	-3.21	-10.38	-1.77	1.73
Interest Coverage Ratio (x)	38.68	7.80	-5.44	-0.72	51.47
Asset Turnover Ratio (x)	0.58	0.50	0.36	0.30	36.03
Price to Earnings (x)	29.94	-37.31	-6.79	-33.11	40.32
Price to Book (x)	1.98	1.50	0.85	0.69	0.81
EV/EBITDA (x)	16.63	41.50	-38.76	-1,251.83	14.84
EBITDA Margin (%)	16.97	5.63	-4.76	-0.15	12.70

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Unichem Labs	12.46	1.16	9.30	4.28	6.76	17.72	5.54	11.48	35.91	2.48	0.17	128.79
Orchid Pharma	228.53	3.61	1.59	2.50	1.07	7.22	5.03	2.61	4.05	2.45	0.28	3.53
Gujarat Themis	90.40	14.66	16.22	15.32	9.27	2.74	39.22	28.15	4.28	1.12	0.56	3.28
IOL Chemicals	28.63	2.19	7.65	11.07	5.32	1.42	9.06	5.93	4.69	1.78	0.07	0.62
Gufic BioSci	57.98	5.60	9.65	14.93	4.78	10.83	13.04	6.80	6.40	1.55	0.58	8.57
Add More

Annual Ratios (%)

Choose from Peers

RPG Life Sci
Aarti Drugs
Solara Active Pharma
Dishman Carbogen
Morepen Labs

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Unichem Labs Stock Performance	-3.25	22.98	29.14	21.95	-26.42	19.90	23.99
Orchid Pharma Stock Performance	8.42	27.51	65.29	37.26	24.28	116.30	-38.13
Gujarat Themis Stock Performance	1.05	3.83	17.07	15.35	23.66	0.00	0.00
IOL Chemicals Stock Performance	5.01	22.76	47.14	83.09	55.60	52.15	8.16
Gufic BioSci Stock Performance	5.12	29.58	27.67	28.66	-0.96	82.43	86.09
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	4,94,40,586	70.22 %	0.00
Pledge	0	0.00 %	0.00
FII	7,02,574	1.00 %	0.01
DII	74,63,600	10.60 %	-0.09
MF	63,84,632	9.07 %	-0.09
Others	1,27,98,990	18.18 %	0.09

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	70.22	70.22	70.22	70.22
Pledge	0.00	0.00	0.00	0.00
FII	1.00	0.99	0.99	0.98
DII	10.60	10.70	10.71	10.89
Mutual Funds	9.07	9.17	9.17	9.39
Others	18.18	18.09	18.08	17.90

Mutual Funds Ownership

MF Ownership as on 30 April 2026

HDFC Small Cap Direct-G
Equity: Small Cap
4
- 212.94
  Amount Invested (in Cr.)
- 0.56%
  % of AUM
- 0.00
  % Change (MoM basis)
DSP Healthcare Direct-G
Equity: Sectoral-Pharma
3
- 33.24
  Amount Invested (in Cr.)
- 1.06%
  % of AUM
- 0.00
  % Change (MoM basis)
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.02
  Amount Invested (in Cr.)
- 0.05663177%
  % of AUM
- -3.64
  % Change (MoM basis)

View all Mutual Fund Schemes

Corporate Actions

Recent
General Meeting
-
Jun 10, 2026
Board Meeting
Audited Results
May 06, 2026
General Meeting
-
Feb 25, 2026

Board Meetings

Announced on	Meeting on
May 06, 2026	May 22, 2026
Audited Results
Jan 09, 2026	Feb 05, 2026
Quarterly Results
Oct 15, 2025	Nov 11, 2025
Quarterly Results
Jul 15, 2025	Aug 04, 2025
Quarterly Results
May 08, 2025	May 22, 2025
Audited Results

Dividends
Announced on Ex-Date Dividend%
May 27, 2022 Aug 01, 2022 200%
May 31, 2021 Jul 22, 2021 200%
Jun 19, 2020 Aug 20, 2020 200%
May 24, 2019 Jul 18, 2019 200%
May 29, 2018 Jul 19, 2018 250%

Announced on	Ex-Date	Dividend%
May 27, 2022	Aug 01, 2022	200%
May 31, 2021	Jul 22, 2021	200%
Jun 19, 2020	Aug 20, 2020	200%
May 24, 2019	Jul 18, 2019	200%
May 29, 2018	Jul 19, 2018	250%

Bonus

Announced on	Ex-Date
Jan 30, 2004	Mar 16, 2004
Bonus Ratio: 1 share(s) for every 1 shares held
Mar 29, 2000	Apr 03, 2000
Bonus Ratio: 1 share(s) for every 1 shares held
Jun 29, 1994	Jul 01, 1994
Bonus Ratio: 1 share(s) for every 2 shares held
Jun 29, 1987	Jul 01, 1994
Bonus Ratio: 1 share(s) for every 2 shares held
Jul 25, 1986	-
Bonus Ratio: 1 share(s) for every 2 shares held

Splits
Announced on Ex-Date
Jul 22, 2010 Oct 21, 2010
Split: Old FV5.0| New FV:2.0
Jan 30, 2004 Mar 16, 2004
Split: Old FV10.0| New FV:5.0
Rights
Announced on Ex-Date
Sep 30, 1993 Aug 06, 1993
Rights ratio: 1 share for every 5 held at a price of Rs 40.0
AGM/EGM Meetings
Announced on Meeting on
Jun 10, 2026 Aug 11, 2026
-
Feb 25, 2026 Mar 29, 2026
-
Jun 20, 2025 Aug 04, 2025
-
Jun 28, 2024 Aug 08, 2024
-
Feb 21, 2024 Mar 24, 2024
-

Announced on	Ex-Date
Jul 22, 2010	Oct 21, 2010
Split: Old FV5.0\| New FV:2.0
Jan 30, 2004	Mar 16, 2004
Split: Old FV10.0\| New FV:5.0

Announced on	Ex-Date
Sep 30, 1993	Aug 06, 1993
Rights ratio: 1 share for every 5 held at a price of Rs 40.0

Announced on	Meeting on
Jun 10, 2026	Aug 11, 2026
-
Feb 25, 2026	Mar 29, 2026
-
Jun 20, 2025	Aug 04, 2025
-
Jun 28, 2024	Aug 08, 2024
-
Feb 21, 2024	Mar 24, 2024
-

About Unichem Labs

Unichem Laboratories Ltd., incorporated in the year 1962, is a Small Cap company (having a market cap of Rs 3,151.36 Crore) operating in Pharmaceuticals sector.

Unichem Laboratories Ltd. key Products/Revenue Segments include Formulations, API and Intermediates, Export Incentives and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 598.59 Crore, up 12.31 % from last quarter Total Income of Rs 532.97 Crore and up .36 % from last year same quarter Total Income of Rs 596.43 Crore. Company has reported net profit after tax of Rs 10.91 Crore in latest quarter.

The company’s top management includes Dr.Prakash A Mody, Mr.Pabitrakumar Bhattacharyya, Mr.Pranay Godha, Mr.Anand Kusre, Mr.Arun Todarwal, Ms.Priti Puri, Mr.Sandip Ghume, Mr.Pradeep Bhandari. Company has N A Shah Associates LLP as its auditors. As on 31-03-2026, the company has a total of 7.04 Crore shares outstanding.

Unichem Labs Share Price Today is Rs. 447.60. On previous day, the Unichem Labs Share Price (NSE) closed at Rs. 462.6, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 70.22% of the stake in Unichem Labs shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Unichem Labs stocks was 1.0% as compared to 0.99% in Dec 2025 with increase of 0.01%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 10.6% as compared to 10.7% in Dec 2025 with decrease of 0.1%. Out of the total DII holdings in Unichem Labs shares 9.07% was held by mutual funds. The rest including public held is 18.18%. Unichem Labs stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Unichem Labs Dividend: Ever since 1962, Unichem Labs dividends has been paid out around 31 times. As on 12 Jun, 2026, 03:58 PM IST, The overall dividend yield for Unichem Labs stands at 0.0%. The last dividend paid was on March 17, 2016 (Rs. 2.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 35.91.

Unichem Labs Bonus: The most recent bonus issue had been in year March 16, 2004 around 22 years ago at 1 : 1 ratio. The first bonus issue was announced in Jul 1986.

Stock Forecast:
After showing 598.59 Cr. of sales and 12.31% of quarterly net profit, there have been multiple ups and downs in the Unichem Labs stock prices in the past few weeks. For example, Unichem Labs stock price on 5th of June 2026 was around Rs. 363.05. Unichem Labs share price now stands at an average of Rs. 447.60. Judging by last week's performance, stock is in up trend.

Unichem Labs has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Unichem Labs share.

Historical Prices and Performance:
Unichem Labs, incorporated in 1962 is a Small Cap company (with a market cap of Rs. 3151.36) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Unichem Labs stock was 9.3%, 5.61%, -2.98%, -8.3% and 1.26% respectively.
The Unichem Labs share gave a 3 year return of 20.71% as compared to Nifty 50 which gave a return of 26.99%.
Unichem Labs announced 100.0% final dividend on March 17, 2016.

Key Metrics:
PE Ratio of Unichem Labs is 12.46
Prices/Sales Ratio of Unichem Labs is 0.94
Price/Book Ratio of Unichem Labs is 1.16

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Unichem Labs, major competitors and peers include Orchid Pharma, Gujarat Themis, IOL Chemicals and Gufic BioSci. As of Dec 2025, the dividend yield of Unichem Labs stands at 0.0% while Orchid Pharma, Gujarat Themis, IOL Chemicals and Gufic BioSci stand at 0.0%, 0.17%, 0.74% and 0.03% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 12.46 and 1.16 respectively.

Leadership of Unichem Labs :
Pradeep Bhandari is Head - Legal & Co. Secretary
Sandip Ghume is Deputy Chief Financial Officer
Prakash A Mody is Chairman, Non Ind & Non Exe Director
Pabitrakumar Bhattacharyya is Managing Director
Pranay Godha is Non Exe.Non Ind.Director
Priti Puri is Independent Director
Anand Kusre is Independent Director
Arun Todarwal is Independent Director

Industry

Pharma - Indian

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE Next 250 Microcap, BSE NEXT 500

Address

47, Kandivli Industrial Estate,Kandivli (West),Mumbai, Maharashtra - 400067

Contact

shares@unichemlabs.com

http://www.unichemlabs.com

PE Ratio(x)	12.46
EPS - TTM(₹)	35.91
MCap(₹ Cr.)	3,151.36
MCap Rank	72
PB Ratio(x)	1.13
Div Yield(%)	-
Face Value(₹)	2.00
52W High(₹)	666.60
52W Low(₹)	278.20
MCap/Sales	0.94
Beta(1 Month)	0.62
BV/Share(₹)	385.97

PE Ratio(x)	12.42
EPS - TTM(₹)	35.91
MCap(₹ Cr.)	3,140.80
MCap Rank	72
PB Ratio(x)	1.20
Div Yield(%)	-
Face Value(₹)	2.00
52W High(₹)	666.00
52W Low(₹)	280.00
MCap/Sales	0.94
Beta(1 Month)	0.50
BV/Share(₹)	385.97

1 Day	-3.25%
1 Month	22.88%
3 Months	33.29%
1 Year	-29.01%
3 Years	20.71%
5 Years	35.74%

1 Day	-3.37%
1 Month	22.47%
3 Months	32.37%
1 Year	-29.09%
3 Years	20.26%
5 Years	35.22%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Unichem Labs - Unichem Laboratories Share Price

Key Metrics

Unichem Labs share price insights

Unichem Labs Share Price Returns

Unichem Labs Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

HDFC Small Cap Direct-G

DSP Healthcare Direct-G

Motilal Oswal BSE Healthcare ETF-G

Unichem Labs Top Searches

Corporate Actions

About Unichem Labs

Executive Leadership

Auditors

FAQs about Unichem Labs share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News